ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,332 | -10.3% | 687 | +1.5% | 0.00% | – |
Q2 2023 | $13,750 | +229066.7% | 677 | +98.0% | 0.00% | – |
Q1 2023 | $6 | -84.6% | 342 | -81.8% | 0.00% | – |
Q4 2022 | $39 | -99.9% | 1,879 | -1.3% | 0.00% | – |
Q3 2022 | $49,000 | +4.3% | 1,904 | +2.0% | 0.00% | – |
Q2 2022 | $47,000 | -23.0% | 1,867 | -2.8% | 0.00% | – |
Q1 2022 | $61,000 | -6.2% | 1,920 | -8.6% | 0.00% | – |
Q4 2021 | $65,000 | -23.5% | 2,100 | -14.3% | 0.00% | -100.0% |
Q3 2021 | $85,000 | +26.9% | 2,450 | 0.0% | 0.00% | – |
Q2 2021 | $67,000 | -2.9% | 2,450 | 0.0% | 0.00% | – |
Q1 2021 | $69,000 | +7.8% | 2,450 | 0.0% | 0.00% | – |
Q4 2020 | $64,000 | – | 2,450 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |